Medtronic Endurant II Stent Graft Gains European Approval


January 18, 2012

January 18, 2011 – Medtronic Inc. announced the CE mark and international launch of the Endurant II AAA stent graft system, which can treat patients with abdominal aortic aneurysms through endovascular aortic repair (EVAR).

An abdominal aortic aneurysm (AAA) is a weakening or bulge in the segment of the aorta, the body’s main artery, which crosses through the abdomen. AAA is often called a “silent killer” because it rarely causes apparent symptoms until rupturing, which usually results in the patient’s death.

Developed in collaboration with more than 250 physicians from around the world and now available in most European countries, the new system encompasses the Endurant stent graft platform while adding new design features that enhance the device’s ease of use.

·         Beginning at the point of access, the new lower-profile delivery system –– with 35 percent extended hydrophilic coating for enhanced access to challenging anatomies –– allows the 28 mm-diameter bifurcated segment (the most commonly used size) to fit inside an 18 French outer diameter catheter (down from 20 French with the original device).

·         Second, the addition of two new contralateral limb lengths (156 and 199 mm) enables more configuration options requiring fewer total pieces.

·         Finally, the radiopacity of the distal end of the bifurcated segment’s contralateral gate has been improved to enhance visibility and aid with limb insertion, placement and deployment.  

In countries where the Endurant II stent graft is approved with the CE mark, the device is indicated for the endovascular treatment of abdominal aortic aneurysms in patients with a proximal neck ≥ 10 mm in length with ≤ 60° infrarenal and ≤ 45° suprarenal angulation and in patients with a proximal aortic neck ≥ 15 mm in length with ≤ 75° infrarenal and ≤ 60° suprarenal angulation.

In the United States, the Endurant II AAA stent graft system is expected to receive approval from the U.S. Food and Drug Administration (FDA) in 2012.

The original Endurant AAA stent graft system received FDA approval in December 2010.

For more information: